Internal Medicine, Gastroenterology · Newark, DE
NPI
1619268620
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4755 Ogletown Stanton Rd, Christiana Hospital
Newark, DE, 19718
Phone (302) 733-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
5,398 services
Medicare patients, 2024
473
Average age 73
Drug cost, 2024
$969K
1,268 prescriptions
Company payments, 2025
$2,865
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura D Connor was code 99214 (office e&m - established), 119 times for 89 patients. In total Laura D Connor billed 5,398 services in 43 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 119 | 89 | $93.90 | $11K |
| 43239 Upper GI Endoscopy | Facility | 106 | 106 | $69.26 | $7,342 |
| 45385 Colonoscopy - Lesion Removal | Facility | 106 | 105 | $202.79 | $21K |
| 45380 Lower GI Endoscopy - Other | Facility | 91 | 91 | $95.07 | $8,651 |
| 99222 Hospital E&M - Initial | Facility | 76 | 76 | $99.85 | $7,589 |
| 99213 Office E&M - Established | Office | 75 | 67 | $64.21 | $4,816 |
| 43450 Digestive/Gastrointestinal | Facility | 22 | 22 | $29.53 | $650 |
| 99203 Office E&M - New | Office | 18 | 18 | $77.11 | $1,388 |
| 99204 Office E&M - New | Office | 17 | 17 | $122.28 | $2,079 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 11 | 11 | $169.58 | $1,865 |
| 43235 Upper GI Endoscopy | Facility | 11 | 11 | $89.89 | $989 |
By year: 2022 $155K for 8,693 services; 2023 $159K for 5,321 services; 2024 $156K for 5,398 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura D Connor prescribed most often to Medicare patients was Omeprazole, with 272 prescriptions and refills. In total Laura D Connor wrote 1,268 Medicare prescriptions that cost $969K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 272 | 619 | 88 | $4,497 |
| Pantoprazole Sodium Generic | 105 | 245 | 37 | $1,557 |
| Linzess Linaclotide | 92 | 150 | 27 | $79K |
| Famotidine Generic | 69 | 199 | 28 | $1,142 |
| Dicyclomine Hcl Generic | 61 | 85 | 21 | $2,056 |
| Amitriptyline Hcl Generic | 54 | 80 | Under 11 | $387 |
| Ondansetron Odt Ondansetron | 34 | 36 | 12 | $615 |
| Metronidazole Generic | 28 | 28 | 14 | $187 |
| Esomeprazole Magnesium Generic | 26 | 58 | Under 11 | $547 |
| Lubiprostone Generic | 25 | 39 | 13 | $3,409 |
| Sucralfate Generic | 24 | 44 | 12 | $2,005 |
| Lansoprazole Generic | 23 | 69 | Under 11 | $867 |
| Prednisone Generic | 21 | 23 | Under 11 | $94.54 |
| Ondansetron Hcl Generic | 19 | 19 | Under 11 | $515 |
| Colestipol Hcl Generic | 19 | 29 | Under 11 | $1,750 |
Brand drugs: - claims; generic drugs: 982 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura D Connor $2,865 ($2,865 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $718.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $718 |
| Janssen Biotech, Inc. JNJ | 15 | $296 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $268 |
| Madrigal Pharmaceuticals MDGL | 12 | $264 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $236 |
| Lilly USA, LLC LLY | 10 | $228 |
| Pfizer Inc. PFE | 10 | $161 |
| Genzyme Corporation SNY | 7 | $158 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $97.87 |
| Ardelyx, Inc. ARDX | 4 | $85.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.